Reuters logo
1 个月内
BRIEF-Trovagene enters into agreement with Astrazeneca to utilize Trovera CTDNA test and services in prospective biomarker study
2017年6月12日 / 中午12点15分 / 1 个月内

BRIEF-Trovagene enters into agreement with Astrazeneca to utilize Trovera CTDNA test and services in prospective biomarker study

1 分钟阅读

June 12 (Reuters) - Trovagene Inc

* Trovagene enters into agreement with astrazeneca to utilize trovera® ctdna test and services in prospective biomarker study

* Trovagene Inc - has entered into an agreement with astrazeneca to provide trovera® urine ctdna biomarker test and services

* Trovagene Inc - trovera egfr urine liquid biopsy test will initially be used in an open label prospective biomarker study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below